Fig. 2From: The prognostic role of pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in esophageal squamous cell carcinoma treated with concurrent chemoradiotherapyThe progression patient. A 75-year-old man presenting with esophageal squamous cell carcinoma, (A) A1: the enhanced chest CT before the treatment, A2: the esophageal barium meal imaging before the treatment; (B) B1: the enhanced chest CT at 6Â months after the treatment, B2: the esophageal barium meal imaging at 6Â months after the treatment; (C) C1: the enhanced chest CT at 18Â months after the treatment, C2: the esophageal barium meal imaging at 18Â months after the treatmentBack to article page